# PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia

> **NCT05839613** · NA · NOT_YET_RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 400 (estimated)

## Conditions studied

- Patients With Schizophrenia

## Interventions

- **DIAGNOSTIC_TEST:** Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)

## Key facts

- **NCT ID:** NCT05839613
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-05
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839613, "PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05839613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*